Yahoo
HKSE - Delayed Quote HKD

Beauty Farm Medical and Health Industry Inc. (2373.HK)

18.830 +0.550 (+3.01%)
As of 3:28:08 PM GMT+8. Market Open.
Chart Range Bar
Loading chart for 2373.HK
  • Previous Close 18.280
  • Open 17.500
  • Bid 18.830 x --
  • Ask 18.970 x --
  • Day's Range 17.500 - 19.500
  • 52 Week Range 15.600 - 30.300
  • Volume 610,500
  • Avg. Volume 232,120
  • Market Cap (intraday) 4.658B
  • Beta (5Y Monthly) 1.35
  • PE Ratio (TTM) 10.52
  • EPS (TTM) 1.790
  • Earnings Date --
  • Forward Dividend & Yield 0.72 (3.94%)
  • 1y Target Est 35.54
  • Moby Rating Neutral

Beauty Farm Medical and Health Industry Inc. provides beauty and health management services in the People's Republic of China. It offers aesthetic medical, and subhealth assessment medical services; and intervention services. The company markets its products under the Beauty Farm, Palaispa, Neology, and CellCare brand names. The company was founded in 1993 and is headquartered in Shanghai, the People's Republic of China.

www.beautyfarm.com.cn

6,975

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/9/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

2373.HK
28.08%
HANG SENG INDEX (^HSI)
4.44%

1-Year Return

2373.HK
32.50%
HANG SENG INDEX (^HSI)
6.67%

3-Year Return

2373.HK
57.06%
HANG SENG INDEX (^HSI)
39.86%

5-Year Return

2373.HK
38.26%
HANG SENG INDEX (^HSI)
1.30%

Analyst Insights

View More

Analyst Price Targets

30.20
35.54 Average
18.830 Current
38.80 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    11.22%

  • Return on Assets (ttm)

    6.54%

  • Return on Equity (ttm)

    34.13%

  • Revenue (ttm)

    3.42B

  • Net Income Avi to Common (ttm)

    384.04M

  • Diluted EPS (ttm)

    1.790

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    2.41B

  • Total Debt/Equity (mrq)

    89.86%

  • Levered Free Cash Flow (ttm)

    1.58B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: